| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 15 Feb 25 | ELEV Elevation Oncology | Common Stock | Payment of exercise | Dispose F | No | No | 0.6717 | 5,189 | 3.49 k | 12,311 |
| 15 Feb 25 | ELEV Elevation Oncology | Common Stock | Option exercise | Acquire M | No | No | 0 | 17,500 | 0.00 | 17,500 |
| 15 Feb 25 | ELEV Elevation Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 0.6717 | 275,000 | 184.72 k | 275,000 |
| 4 Oct 24 | OKUR OnKure Therapeutics | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 18.2 | 15,300 | 278.46 k | 15,300 |
| 15 Feb 24 | ELEV Elevation Oncology | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 17,500 | 0.00 | 52,500 |
| 15 Feb 24 | ELEV Elevation Oncology | RSU Common Stock | Grant | Acquire A | No | No | 0 | 70,000 | 0.00 | 70,000 |
| 15 Feb 24 | ELEV Elevation Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 2.77 | 225,000 | 623.25 k | 225,000 |
